04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Over the last two years, the Nevada Legislature has passed a substantial number of laws affecting Ne...
Read More >
Limited partnerships and limited liability companies, as creatures of contract, often have in their ...
Read More >
On the 1st July 2019, reform for whistleblowing laws in Australia came into effect. These contain si...
Read More >
AIFMD review: European Commission consultation - The European Commission has launched a consultatio...
Read More >
The Eighth Circuit recently concluded that there was no contractual basis to conclude that a pharmac...
Read More >
An arbitrator could bind absent class members to a Title VII and Equal Pay Act (EPA) class action wh...
Read More >